{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:36:40Z","timestamp":1773884200816,"version":"3.50.1"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.27551","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T05:34:36Z","timestamp":1607146476000},"page":"e2027551","source":"Crossref","is-referenced-by-count":19,"title":["Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation"],"prefix":"10.1001","volume":"3","author":[{"given":"Ben L.","family":"Da","sequence":"first","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Sandra Atlas Bass Center for Liver Diseases & Transplantation, Division of Hepatology, Department of Internal Medicine, Donald and Barbara Zucker School of Medicine for Hofstra\/Northwell Health, Manhasset, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghideon","family":"Ezaz","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Kushner","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Crismale","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Kakked","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Gurakar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Dieterich","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Saberi","sequence":"additional","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"zoi200885r1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/ajt.2019.19.issue-S2","article-title":"OPTN\/SRTR 2017 Annual data report: liver.","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi200885r2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12876-016-0551-z","article-title":"Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.","volume":"16","author":"Stepanova","year":"2016","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"zoi200885r3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/j.1600-6143.2011.03518.x","article-title":"Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States.","volume":"11","author":"Ellingson","year":"2011","journal-title":"Am J Transplant"},{"issue":"10","key":"zoi200885r4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"50-51","key":"zoi200885r5","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000-2014.","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"zoi200885r6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","article-title":"Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis.","volume":"23","author":"Northup","year":"2010","journal-title":"Transpl Int"},{"issue":"4","key":"zoi200885r7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00007890-200202270-00018","article-title":"The outcome of liver grafts procured from hepatitis C-positive donors.","volume":"73","author":"Velidedeoglu","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"zoi200885r8","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12982","article-title":"Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.","volume":"20","author":"Shaffer","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"zoi200885r10","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hep.30540","article-title":"Increasing utilization and excellent initial outcomes following liver transplant of hepatitis c virus (HCV)-viremic donors into HCV-negative recipients: outcomes following liver transplant of HCV-viremic donors.","volume":"69","author":"Cotter","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"zoi200885r11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/lt.24838","article-title":"Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.","volume":"24","author":"Saberi","year":"2018","journal-title":"Liver Transpl"},{"issue":"6","key":"zoi200885r12","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13194","article-title":"Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.","volume":"21","author":"Ting","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"zoi200885r13","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation.","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi200885r14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.v71.1","article-title":"Utilization of hepatitis C virus (HCV)-viremic organs for HCV negative recipients: is practice speeding past the evidence?","volume":"71","author":"Verna","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"zoi200885r15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/s10620-018-5404-x","article-title":"Use of hepatitis C-positive liver grafts in hepatitis C-negative recipients.","volume":"64","author":"Shetty","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"3","key":"zoi200885r16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. a report from the European Liver Transplant Registry (ELTR).","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"zoi200885r17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"issue":"7","key":"zoi200885r18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/lt.v16:7","article-title":"The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.","volume":"16","author":"Spitzer","year":"2010","journal-title":"Liver Transpl"},{"issue":"2","key":"zoi200885r19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C-infected donor livers in the recent era.","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"zoi200885r21","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/hep.v67.4","article-title":"The rise of the opioid epidemic and hepatitis C-positive organs: A new era in liver transplantation.","volume":"67","author":"Gonzalez","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"zoi200885r22","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic.","volume":"16","author":"Goldberg","year":"2016","journal-title":"Am J Transplant"},{"issue":"9","key":"zoi200885r24","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/ajt.2017.17.issue-9","article-title":"Geographic disparities in liver availability: accidents of geography, or consequences of poor social policy?","volume":"17","author":"Ladin","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"zoi200885r26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1200\/JOP.18.00525","article-title":"The cost of cure: barriers to access for hepatitis C virus treatment in south Texas.","volume":"15","author":"Tenner","year":"2019","journal-title":"J Oncol Pract"},{"issue":"6","key":"zoi200885r27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ajg.2017.87","article-title":"Medicaid reimbursement for oral direct antiviral agents for the treatment of chronic hepatitis C.","volume":"112","author":"Ooka","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"zoi200885r28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jvh.2016.23.issue-6","article-title":"Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.","volume":"23","author":"Younossi","year":"2016","journal-title":"J Viral Hepat"},{"issue":"7","key":"zoi200885r29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cgh.2016.03.040","article-title":"Disparities in absolute denial of modern hepatitis C therapy by type of insurance.","volume":"14","author":"Lo Re","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"zoi200885r30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000495263","article-title":"Use of hepatitis C positive organs: patient attitudes in urban Chicago.","volume":"49","author":"Couri","year":"2019","journal-title":"Am J Nephrol"},{"issue":"1","key":"zoi200885r31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.29916","article-title":"Social media: why AASLD and its members must lead the conversation.","volume":"68","author":"Heller","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"zoi200885r32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00004836-200603000-00009","article-title":"Social stigmatization and hepatitis C virus infection.","volume":"40","author":"Zacks","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"zoi200885r9","author":"Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic","year":"2020"},{"key":"zoi200885r20","unstructured":"Foundation? HJKF. Opioid overdose deaths and opioid overdose deaths as a percent of all drug overdose deaths, analysis of CDC National Center for Health Statistics. Accessed January 10th, 2020. https:\/\/www.kff.org\/state-category\/health-status\/opioids\/?"},{"key":"zoi200885r23","unstructured":"Percentage of adult population in the U.S. who register as organ donors when given the opportunity as of 2018, by state. Published 2018. Accessed January 10th, 2020. https:\/\/www.statista.com\/statistics\/624834\/state-designated-organ-donors-among-us-adults-by-state\/?"},{"key":"zoi200885r25","unstructured":"Organ Procurement and Transplantation Network. Accessed November 16, 2020. https:\/\/optn.transplant.hrsa.gov\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2773540\/da_2020_oi_200885_1605908627.43975.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:08:30Z","timestamp":1697303310000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2773540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.27551","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}